Children (Oct 2022)

Risk Factors for Lung Function Decline in Pediatric Asthma under Treatment: A Retrospective, Multicenter, Observational Study

  • Shingo Yamada,
  • Takao Fujisawa,
  • Mizuho Nagao,
  • Hiroshi Matsuzaki,
  • Chikako Motomura,
  • Hiroshi Odajima,
  • Toshinori Nakamura,
  • Takanori Imai,
  • Ken-ichi Nagakura,
  • Noriyuki Yanagida,
  • Masatoshi Mitomori,
  • Motohiro Ebisawa,
  • Shigenori Kabashima,
  • Yukihiro Ohya,
  • Chizu Habukawa,
  • Minako Tomiita,
  • Masahiro Hirayama

DOI
https://doi.org/10.3390/children9101516
Journal volume & issue
Vol. 9, no. 10
p. 1516

Abstract

Read online

Background: Childhood asthma is a major risk for low lung function in later adulthood, but what factors in asthma are associated with the poor lung function during childhood is not known. Objective: To identify clinical factors in children with asthma associated with low or declining lung function during the treatment. Methods: We enrolled children with asthma who had been treated throughout three age periods, i.e., 6–9, 10–12, and 13–15 years old, at seven specialized hospitals in Japan. Clinical information and lung function measurements were retrieved from the electronic chart systems. To characterize the lung function trajectories during each age period, we evaluated the forced expiratory volume 1 (FEV1) with % predicted values and individual changes by the slope (S) from linear regression. We defined four trajectory patterns: normal (Group N) and low (Group L), showing %FEV1 ≥80% or n = 150)/U (n = 47), while 76 (28%) were in Group D (n = 66)/L (n = 10). A history of poor asthma control, long-acting beta2 agonist use, and a lower height Z-score during 13–15 years were associated with an unfavorable outcome (Group D/L). Conversely, inhaled corticosteroid (ICS) use during 10–12 years and high-dose ICS use during 13–15 years were associated with a favorable outcome (Group N/U). Conclusion: We identified several factors that are associated with unfavorable lung function changes in pediatric asthma. Attention should be paid to the possible relationship between yearly changes in lung function and poor asthma control, use of ICS (and its dose) and use of LABA.

Keywords